The efficacy of two formulations of botulinum toxin type A for masseter reduction: a split-face comparison study
Background: Botulinum toxin type A (BTA) is now extensively used to address cosmetic concerns. OnabotulinumtoxinA (ONA, Botox; Allergan Inc., Irvine, CA) received FDA approval for upper face rejuvenation, including glabella frown lines and crow’s-feet lines. The other off-label uses for lower face c...
Main Authors: | Rungsima Wanitphakdeedecha, Chanida Ungaksornpairote, Arisa Kaewkes, Angkana Sathaworawong, Nittaya Lektrakul, Woraphong Manuskiatti |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-07-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2016.1263382 |
Similar Items
-
The evaluation of the relationship between changes in masseter muscle thickness and tooth clenching habits of bruxism patients treated with botulinum toxin A
by: Deniz Erdil, et al.
Published: (2023-01-01) -
Botulinum Toxin in the Treatment of Headache
by: Werner J. Becker
Published: (2020-12-01) -
Biphasic Injection for Masseter Muscle Reduction with Botulinum Toxin
by: Fabrizio Chirico, et al.
Published: (2021-07-01) -
Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
by: Travis J.W. Hassell, et al.
Published: (2020-04-01) -
Facial liposuction combined with botulinum toxin type A: A technique for lower facial contouring
by: Chunjie Li, et al.
Published: (2021-09-01)